- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04984252
Testing a Brief and Low Intensity Self-compassion Intervention
September 27, 2021 updated by: Fidan Turk, University of Sheffield
Testing a Brief and Low Intensity Self-compassion Intervention for State Body Shame Among Adult Women: a Randomized Controlled Trial
The investigators' recent feasibility trial of a self-compassion and active control intervention showed that the self-compassion intervention was promising in reducing state body shame during a 40-minute intervention session.
There were three time points where the reduction in the body shame level was significant, indicating three active components in the intervention that led to significant reduction in state body shame.
It is unclear if a shorter self-compassion intervention based on only the active components would be as effective as the longer intervention at reducing state body shame.
Such a short intervention then could be used as an in-session change method (15-20 mins) as part of a larger package, or as a homework exercise.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sheffield, United Kingdom, S1 2LT
- Fidan Turk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age ≥ 18 years
- Self-identified women
- Be able to use a computer and have an Internet connection
Exclusion Criteria:
- Insufficient knowledge of English
- Learning disability or psychiatric illness requiring secondary care intervention
- Male
- Under 18 years old
- No access to a tablet or computer with an internet connection
- Body mass index below 18.5
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Only Active components
15 minutes, once
|
This intervention includes 3 short meditations that are identified as the active component in the previous study (ID: NCT04665167)
|
Sham Comparator: Inactive components
15 minutes, once
|
This intervention includes 3 short meditations that are identified as the inactive component in the previous study (ID: NCT04665167)
|
Placebo Comparator: Distraction group
15 minutes, once
|
Participants will be asked to listen recording on irrelevant topic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Subjective units of shame (SUS) at the end of the intervention
Time Frame: through study completion, an average of 3 months
|
Subjective units of shame (SUS), taken at four points during the intervention (scored 0 no shame to 100 full of shame)
|
through study completion, an average of 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Image States Scale
Time Frame: through study completion, an average of 3 months
|
It will be used to assess transient feelings about the body and physical appearance.
A 6-item scale measures current body-image experiences at a particular point in time or in a specific context.
Possible scores range from 6 to 54, and higher scores indicate more positive body image (better outcome).
|
through study completion, an average of 3 months
|
Shame subscale of the State Shame and Guilt Scale
Time Frame: through study completion, an average of 3 months
|
It will be used to test state shame.
Possible scores are ranged from 5 to 25.
Higher scores indicate worse state shame.
|
through study completion, an average of 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2021
Primary Completion (Actual)
September 16, 2021
Study Completion (Actual)
September 18, 2021
Study Registration Dates
First Submitted
July 8, 2021
First Submitted That Met QC Criteria
July 20, 2021
First Posted (Actual)
July 30, 2021
Study Record Updates
Last Update Posted (Actual)
October 5, 2021
Last Update Submitted That Met QC Criteria
September 27, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 040360
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Image Disturbance
-
Southern Illinois University EdwardsvilleTerminatedBody Image DisturbanceUnited States
-
Norwegian School of Sport SciencesUniversity of Agder; Ostfold University College; University College of Southeast...CompletedQuality of Life | Physical Activity | Dietary Habits | Body Image Disturbance | Body ImageNorway
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); The Fenway InstituteUnknownMedication Adherence | Body Image DisturbanceUnited States
-
York UniversityRecruitingBody Image Disturbance | Body Dysmorphic DisorderCanada
-
Medical University of South CarolinaNational Cancer Institute (NCI)RecruitingHead and Neck Cancer | Body Image Disturbance | Body Image | Psychosocial Impairment | Survivorship | Mental Health IssueUnited States
-
Istanbul Arel UniversityIstanbul UniversityCompletedBody Image Disturbance | Eating DisordersTurkey
-
University of SheffieldCompletedBody Image Disturbance | Eating Disorder SymptomUnited Kingdom
-
Union College, New YorkUniversity at AlbanyCompletedBody Image Disturbance | Eating Disorder SymptomUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingWeight Loss | Overweight and Obesity | Body Image DisturbanceUnited States
-
University of California, San DiegoMichael and Arlene Rosen FoundationCompletedBody Image Disturbance | Eating Disorders | Eating Disorder Symptom | DysmorphiaUnited States
Clinical Trials on Self-compassion comprising compassionate body scan-1, compassion body scan-2 and short noticing practice
-
Fred Hutchinson Cancer CenterNational Cord Blood NetworkRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Hematopoietic and Lymphoid System Neoplasm | Blastic Plasmacytoid Dendritic Cell Neoplasm | Myeloproliferative Neoplasm | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Chronic...United States
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
Children's Oncology GroupRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Mixed Phenotype Acute LeukemiaUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia
-
Hospital Universitari de BellvitgeTerminated